Literature DB >> 10346894

Effects of chirality at Tyr13 on the structure-activity relationships of omega-conotoxins from Conus magus.

K J Nielsen1, D A Adams, P F Alewood, R J Lewis, L Thomas, T Schroeder, D J Craik.   

Abstract

The effects of chirality inversions of Tyr13 on the structure-activity relationships of omega-conotoxins MVIIA and MVIIC were examined using a combination of 2D 1H NMR spectroscopy and radioligand binding studies specific for N-type ([125I]GVIA) and P/Q-type ([125I]MVIIC) voltage-sensitive calcium channels (VSCCs). A comparison of the Halpha secondary shifts suggests that the structural scaffolds of MVIIA and MVIIC are little altered by the L- to D- inversion of Tyr13; however, the conformations of several residues in loop 2 (residues 9-14) are significantly altered. The experimentally determined 3D structure of [D-Y13]MVIIA indicates that the positions of key residues in this loop which are involved in the binding of MVIIA to the N-type VSCC (Tyr13, Arg10, and Leu11) are so changed as to render the peptide unrecognizable by its cognate ion channel. The large reduction in potency observed for MVIIA and MVIIC at both N-type and P/Q-type VSCCs is likely to stem from the change in conformation and orientation of loop 2.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10346894     DOI: 10.1021/bi982980u

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  9 in total

1.  Solution structure and backbone dynamics of an omega-conotoxin precursor.

Authors:  D P Goldenberg; R E Koehn; D E Gilbert; G Wagner
Journal:  Protein Sci       Date:  2001-03       Impact factor: 6.725

2.  The three-dimensional structural surface of two beta-sheet scorpion toxins mimics that of an alpha-helical dihydropyridine receptor segment.

Authors:  Daniel Green; Suzi Pace; Suzanne M Curtis; Magdalena Sakowska; Graham D Lamb; Angela F Dulhunty; Marco G Casarotto
Journal:  Biochem J       Date:  2003-03-01       Impact factor: 3.857

Review 3.  P/Q-type calcium channel modulators.

Authors:  V Nimmrich; G Gross
Journal:  Br J Pharmacol       Date:  2012-10       Impact factor: 8.739

Review 4.  Targeting voltage-gated calcium channels: developments in peptide and small-molecule inhibitors for the treatment of neuropathic pain.

Authors:  S Vink; P F Alewood
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

5.  SO-3, a new O-superfamily conopeptide derived from Conus striatus, selectively inhibits N-type calcium currents in cultured hippocampal neurons.

Authors:  Lei Wen; Sheng Yang; Haifa Qiao; Zhenwei Liu; Wenxia Zhou; Yongxiang Zhang; Peitang Huang
Journal:  Br J Pharmacol       Date:  2005-07       Impact factor: 8.739

6.  Effects of arginine 10 to lysine substitution on ω-conotoxin CVIE and CVIF block of Cav2.2 channels.

Authors:  G Berecki; N L Daly; Y H Huang; S Vink; D J Craik; P F Alewood; D J Adams
Journal:  Br J Pharmacol       Date:  2014-07       Impact factor: 8.739

Review 7.  Discovery, synthesis, and structure-activity relationships of conotoxins.

Authors:  Kalyana B Akondi; Markus Muttenthaler; Sébastien Dutertre; Quentin Kaas; David J Craik; Richard J Lewis; Paul F Alewood
Journal:  Chem Rev       Date:  2014-04-10       Impact factor: 60.622

8.  Ziconotide: a review of its pharmacology and use in the treatment of pain.

Authors:  Joseph G McGivern
Journal:  Neuropsychiatr Dis Treat       Date:  2007-02       Impact factor: 2.570

Review 9.  Bioactive Mimetics of Conotoxins and other Venom Peptides.

Authors:  Peter J Duggan; Kellie L Tuck
Journal:  Toxins (Basel)       Date:  2015-10-16       Impact factor: 4.546

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.